CanaQuest Medical Corp.

MISSISSAUGA, A6 · CIK 0001607679 · Biotech · Public

Medical cannabis formulations and therapeutics developed through scientific research

canaquest.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$31K
2 Form D · Oct 2022
47 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$30,710
Private capital raisedForm D · SEC$2,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1824Discgenics, Inc.—$870K
1825Prairie Pharms, LLC—$455K
1826Magna Pharmaceuticals, Inc.—$1.0M
1827CanaQuest Medical Corp.—$31K
1828NMN Holdings LP——
1829Reven Pharmaceuticals, Inc.—$23K
1830Harton, Inc.—$15M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Gordon EastleyDirector · Executive Officer
  • Ross EastleyDirector · Executive Officer
  • Sandra ElsleyExecutive Officer
  • Cameron McDonaldDirector
  • Paul RamsayDirector · Executive Officer
  • Richard RusiniakDirector · Executive Officer

Patents

USPTO · 0 granted of 1
  • Composition For Treating Epilepsyapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.